A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA.

Andhika RachmanAnggraini IrianiLugyanti SukrismanWulyo RajabtoNadia Ayu MulansariAnna Mira LubisRahmat CahyanurFindy PrasetyawatiDimas PriantonoBayu Bijaksana RumondorRachelle BetsySamuel Juanputra

Published in: PloS one (2023)

Generally, mRNA vaccines produced significantly higher anti-SARS-CoV-2 S-RBD IgG and NAb levels than non-mRNA vaccines in cancer subjects.

Keyphrases

sars cov
binding protein
coronavirus disease
respiratory syndrome coronavirus
squamous cell carcinoma
squamous cell